Incidence of Direct Oral Anticoagulant use in patients with non‐valvular atrial fibrillation and characteristics of users in six European countries (2008‐2015): A cross‐national drug utilization study.

Aims To estimate the incidence of direct oral anticoagulant drug (DOAC) use in patients with nonvalvular atrial fibrillation and to describe user and treatment characteristics in 8 European healthcare databases representing 6 European countries.